Which of the following dictates the use of Herceptin in breast cancer treatment?
A)If Herceptin is found in the breast lymph nodes of the patient. B)If HER2, administered by injection, is in sufficient concentration. C)If the patient's cancer cells have excessive levels of HER2. D)If the patient's genome codes for the HER2 receptor. E)If the patient's genome codes for the manufacture of Herceptin.